Literature DB >> 785428

Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine.

W G Laver, R G Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 785428      PMCID： PMC2496313          DOI： 10.1136/pgmj.52.608.373

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS.

Authors:  W G LAVER
Journal:  J Mol Biol       Date:  1964-07       Impact factor: 5.469

Review 2.  Antibody response to viral antigens.

Authors:  K M Cowan
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains.

Authors:  W G Laver; J C Downie; R G Webster
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

4.  Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus.

Authors:  W G Laver; R C Valentine
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

5.  Reactions to an influenza virus vaccine in infants and children.

Authors:  J J QUILLIGAN; T FRANCIS; E MINUSE
Journal:  Am J Dis Child       Date:  1949-09

6.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307
  6 in total
  7 in total

1.  Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Authors:  Felix W Santiago; Kris Lambert Emo; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2012-05-15       Impact factor: 3.641

2.  Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.

Authors:  W E Beyer; A M Palache; A D Osterhaus
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

3.  Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

Authors:  Zachary R Sia; Matthew S Miller; Jonathan F Lovell
Journal:  Mol Pharm       Date:  2020-08-17       Impact factor: 4.939

Review 4.  Novel Platforms for the Development of a Universal Influenza Vaccine.

Authors:  Arun Kumar; Trine Sundebo Meldgaard; Sylvie Bertholet
Journal:  Front Immunol       Date:  2018-03-23       Impact factor: 7.561

Review 5.  Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.

Authors:  Daniela S Rajão; Daniel R Pérez
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 6.  Substantial effect of phytochemical constituents against the pandemic disease influenza-a review.

Authors:  A Brindha Devi; R Sarala
Journal:  Futur J Pharm Sci       Date:  2021-06-12

7.  WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine.

Authors:  Fang He; Yuenfern Ho; Li Yu; Jimmy Kwang
Journal:  BMC Microbiol       Date:  2008-12-31       Impact factor: 3.605
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.